Folio Search · free preview

Papers on “continuous glucose monitoring diabetes management”

Live results from Semantic Scholar, CrossRef and OpenAlex — no account needed to look.

1. Real-Time Type 1 Diabetes Self-Management Decision-Making in Adolescents: Protocol for a Longitudinal Mixed Methods Study Using Text Messaging and Continuous Glucose Monitoring

   M. DeJonckheere, S. Chuisano, Juniar Lucien, et al. · 2026 · JMIR Research Protocols · 25,016 cites

   Abstract Background Type 1 diabetes (T1D) requires repeated self-management behaviors and ongoing problem-solving to maintain optimal glucose levels and prevent complications. Despite increasing adoption of continuous glucose monitoring (CGM), which can alleviate some of the constant self-management burden, adolescents struggle to achieve glycemic recommendations and report low engagement with diabetes device data. Previous studies have used retrospective or quantitative approaches to describe adolescent self-management; however, it is unclear how psychosocial influences (eg, mood and distress) and contexts impact adolescent self-management behaviors and engagement with their diabetes device

2. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications

   G. Cappon, M. Vettoretti, G. Sparacino, et al. · 2019 · Diabetes & Metabolism Journal · 406 cites

   By providing blood glucose (BG) concentration measurements in an almost continuous-time fashion for several consecutive days, wearable minimally-invasive continuous glucose monitoring (CGM) sensors are revolutionizing diabetes management, and are becoming an increasingly adopted technology especially for diabetic individuals requiring insulin administrations. Indeed, by providing glucose real-time insights of BG dynamics and trend, and being equipped with visual and acoustic alarms for hypo- and hyperglycemia, CGM devices have been proved to improve safety and effectiveness of diabetes therapy, reduce hypoglycemia incidence and duration, and decrease glycemic variability. Furthermore, the re

3. The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes

   · 2009 · Diabetes Care · 352 cites

   OBJECTIVE The potential benefits of continuous glucose monitoring (CGM) in the management of adults and children with well-controlled type 1 diabetes have not been examined. RESEARCH DESIGN AND METHODS A total of 129 adults and children with intensively treated type 1 diabetes (age range 8–69 years) and A1C <7.0% were randomly assigned to either continuous or standard glucose monitoring for 26 weeks. The main study outcomes were time with glucose level ≤70 mg/dl, A1C level, and severe hypoglycemic events. RESULTS A

4. Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment

   · 2010 · Diabetes Care · 295 cites

   OBJECTIVE To determine whether continuous glucose monitoring (CGM) is effective in the management of type 1 diabetes when implemented in a manner that more closely approximates clinical practice. RESEARCH DESIGN AND METHODS After completion of a 6-month randomized controlled trial (RCT) evaluating CGM in children, adolescents, and adults with type 1 diabetes, CGM was initiated in the trial's control group with less intensive training and follow-up than was included in the RCT. Subjects had an outpatient training session, two follow-up phone calls, and outpatient visits at 1, 4, 13, and 26

5. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring

   M. Yapanis, S. James, M. Craig, et al. · 2022 · The Journal of Clinical Endocrinology and Metabolism · 239 cites

   Abstract Context Although glycated hemoglobin A1c is currently the best parameter used clinically to assess risk for the development of diabetes complications, it does not provide insight into short-term fluctuations in glucose levels. This review summarizes the relationship between continuous glucose monitoring (CGM)-derived metrics of glycemic variability and diabetes-related complications. Evidence Acquisition PubMed and Embase databases were searched from January 1, 2010 to August 22, 2020, using the terms type 1 diabetes, type 2 diabetes, diabetes-related microvascular and macrovascular complications, and measures of glycaemic variability. Exclusion criteria were studies that did not us

6. Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes

   · 2009 · Diabetes Care · 220 cites

   OBJECTIVE To evaluate factors associated with successful use of continuous glucose monitoring (CGM) among participants with intensively treated type 1 diabetes in the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Clinical Trial. RESEARCH DESIGN AND METHODS The 232 participants randomly assigned to the CGM group (165 with baseline A1C ≥7.0% and 67 with A1C <7.0%) were asked to use CGM on a daily basis. The associations of baseline factors and early CGM use with CGM use ≥6 days/week in the 6th month and with change in A1C from baseline to 6 months wer

7. Prolonged Nocturnal Hypoglycemia Is Common During 12 Months of Continuous Glucose Monitoring in Children and Adults With Type 1 Diabetes

   · 2010 · Diabetes Care · 154 cites

   OBJECTIVE To characterize the amount of nocturnal hypoglycemia and evaluate factors associated with nocturnal hypoglycemia assessed with continuous glucose monitoring (CGM) in adults and children with type 1 diabetes who participated in the Juvenile Diabetes Research Foundation CGM randomized clinical trial. RESEARCH DESIGN AND METHODS The analysis included 36,467 nights with ≥4 h of CGM glucose readings between 12 midnight and 6:00 a.m. from 176 subjects assigned to the CGM group of the trial. The percentage of nights in which hypoglycemia occurred (two consecutive CGM readings ≤60 mg/dl

8. Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Nondiabetic Individuals

   · 2010 · Diabetes Care · 118 cites

   OBJECTIVE To characterize glucose levels during daily living using continuous glucose monitors (CGMs) in nondiabetic individuals. RESEARCH DESIGN AND METHODS Seventy-four healthy children, adolescents, and adults aged 9–65 years with normal glucose tolerance used a blinded CGM device for 3 to 7 days. RESULTS Sensor glucose concentrations were 71–120 mg/dl for 91% of the day. Sensor values were ≤60 or >140 mg/dl for only 0.2% and 0.4% of the day, respectively. Sensor glucose concentrations were slightly higher in ch